Lord, Abbett & Co. LLC Rx Sight, Inc. Call Options Transaction History
Lord, Abbett & Co. LLC
- $30.4 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RXST
# of Institutions
198Shares Held
25.6MCall Options Held
67KPut Options Held
2K-
Black Rock Inc. New York, NY2.11MShares$127 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.9MShares$114 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.52MShares$91.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.13MShares$67.7 Million0.0% of portfolio
-
Summit Partners Public Asset Management, LLC Boston, MA783KShares$47.1 Million1.43% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.66B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...